SA
Srinivas Akkaraju
DELAYED 1 MONTH
Director; Director, 10% Owner
Kalaris Therapeutics, Inc.
Scholar Rock Holding Corp
Filings
3
Companies
2
Latest
Jun 4, 2026
Transactions
Signal
Ticker / Company
Insider
Transaction
Value
Filed
63
Kalaris Therapeutics, Inc.
Srinivas Akkaraju
Director, 10% Owner
Purchase
$1.2M
244,300 sh
May 22 11:47 PM
May 20, 2026